IngentaConnect Femtomole immunodetection of synthetic and endogenous amyloid- ol...

Authors: Chang, Lei¹; Bakhos, Lara¹; Wang, Zhiqiang²; Venton, Duane²; Klein, William³

Source: Journal of Molecular Neuroscience, Volume 20, Number 3, August 2003 , pp. 305-313(9)

Abstract:

Alzheimer's disease (AD) is a fatal, progressive dementia for which there is no cure and for which a molecular basis has yet to be established. However, considerable evidence suggests that AD is linked to neurotoxic assemblies of the 42-amino-acid peptide amyloid β (Aβ). There is now a clear body of evidence that shows this neurotoxicity resides not only in insoluble fibrils of Aβ but also in soluble Aβ ADDLs (Aβ-derived diffusible ligands) and larger protofibrils. Further, anti-Aβ antibodies have been reported to reverse memory failure in human amyloid precursor protein (hAPP)-expressed transgenic mice in a manner that suggests symptom reversal is attributable to targeting of ADDLs. Clearly, a search for drugs targeting the assembly of these soluble Aβ species represents a new and potentially important approach to the treatment of AD. In this work we describe the development of a dot-blot immunoassay to measure ADDL at the femtomole level, its use in defining the time course of ADDL formation, and its use in determining the presence of ADDLs in the hAPP transgenic mouse brain. Discussion of a protocol to screen agents for inhibition of neurotoxic ADDL formation both in vivo and in vitro is also presented. The methods are suitable for screening combinatorial libraries and, importantly, provide the potential for simultaneous information on candidate transport across the blood-brain barrier.

Keywords: Amyloid-β; Alzheimer's disease; oligomers; cyclodextrin; drug screening; ADDLs

Document Type: Research article

DOI: 10.1385/JMN:20:3:305

Affiliations: 1: Department of Neurobiology and Physiology, Northwestern University, 60208, Evanston, IL, 2: Department of Medicinal Chemistry and Pharmacognosy, The University of Illinois at Chicago, 60612, Chicago, IL, 3: Department of Neurobiology and Physiology, Northwestern University, 60208, Evanston, IL, Email: wklein@northwestern.edu

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$42.00 plus tax Refund Policy

Femtomole immunodetection of synthetic and endogenous amyloid-β oligomers and its application to Alzheimer's disease drug candidate screening